NY-ESO-1 Protein Vaccine Plus Montanide ISA-51 VG

A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1) and emulsified in the immunoadjuvant Montanide ISA-51 VG, with potential immunomodulating and antineoplastic activities. Upon subcutaneous vaccination, the NY-ESO-1 protein vaccine emulsified in Montanide ISA-51 VG may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response against tumor cells expressing the NY-ESO-1 antigen, resulting in tumor cell lysis. NY-ESO-1, an antigen found in normal testes and various tumors, including bladder, breast, hepatocellular, melanoma, and prostate cancers. The surfactant mannide monooleate in Montanide ISA 51 VG is derived from vegetable-grade (VG) oleic acid that was purified from olive oil. (NCI Thesaurus)

YOU MAY ALSO LIKE

NY-ESO-1 Plasmid DNA Cancer Vaccine

A plasmid DNA encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1 with potential immunostimulating and antitumor activities. Upon administration, NY-ESO-1…

NY-ESO-1 Peptide Vaccine

A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an antigen found in normal testis and various…

NX Stage Finding

A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.

NWTS Regimen 1

A regimen consisting of vincristine, doxorubicin, etoposide alternating with cyclophosphamide and etoposide, administered with radiation therapy and used for the treatment of…

NV1020

A genetically engineered oncolytic virus with potential antineoplastic property. NV1020 is constructed from the herpes simplex virus 1 (HSV-1) by the deletion…

Nux Vomica Seed

An herbal remedy derived from the seeds of the evergreen tree Strychnos nux-vomica, a native to southeast Asia and northern Australia. The…